VWF and thrombotic thrombocytopenic purpura: At concentrations found in plasma of patients with inherited and acquired TTP (0.1 μg/mL)50, rADAMTS13 had no effect on vWF associated to the endothelial surface after buffer perfusion (Fig. S3e) and only slightly reduced it when plasma was added (Fig. 5f).